Reaction
Testicular Atrophy reporting signals
As of the last recalculation, Testicular Atrophy appears in 859 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is FINASTERIDE (PRR 128.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Finasteride | 234 | 128.8 | 129.3 |
| Relugolix | 47 | 51.0 | 51.1 |
| Testosterone | 43 | 46.9 | 47.0 |
| Dronabinol | 10 | 30.5 | 30.5 |
| Phenobarbital | 17 | 29.0 | 29.0 |
| Bicalutamide | 17 | 27.6 | 27.6 |
| Testosterone Cypionate | 10 | 27.4 | 27.5 |
| Leuprolide Acetate | 76 | 25.9 | 26.0 |
| Entecavir | 8 | 16.7 | 16.8 |
| Apalutamide | 7 | 14.5 | 14.5 |
| Enzalutamide | 26 | 11.0 | 11.0 |
| Minoxidil Foam 5% (Womens) | 14 | 10.4 | 10.4 |
| Cannabidiol | 8 | 8.4 | 8.4 |
| Minoxidil | 15 | 8.2 | 8.2 |